EXEL – exelixis, inc. (US:NASDAQ)

News

Exelixis: The Cash-Generating Biotech That I Think Deserves a Closer Look in 2026 [Yahoo! Finance]
A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts [Yahoo! Finance]
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Exelixis, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at Royal Bank Of Canada from $45.00 to $46.00. They now have a "sector perform" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com